Centiva Capital’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Centiva Capital's ELV Position: Q2 2026 in Review
Centiva Capital increased its Elevance Health (ELV) stake by 37% in Q2 2026, buying an estimated $109K and bringing the position to 1,093 shares worth $423K. The position accounts for ﹤0.01% of the portfolio, ranked #1000.
Centiva Capital first reported a position in ELV in Q4 2019 and has held it in 17 quarters since. The position peaked at $3.88M in Q3 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Centiva Capital held 1,093 shares of Elevance Health worth $423K as of Q2 2026.
- Centiva Capital bought 293 Elevance Health shares in Q2 2026, an estimated $109K.
- Elevance Health made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1000 holding.
- Centiva Capital first reported a position in Elevance Health in Q4 2019 and has held it in 17 quarters since.
- Centiva Capital's Elevance Health position peaked at $3.88M in Q3 2024.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.